Noveris Health Sciences Inc. (MYCOF)
OTC Markets OTCPK · USD · Healthcare · Drug Manufacturers - Specialty & Generic
$0.73 (+0.00%) as of
Key statistics
- Market cap
- 42.74M
- P/E (TTM)
- 0.39
- Forward P/E
- 0.29
- EPS (TTM)
- 1.8900
- Dividend yield
- 0.00%
- 52-week range
- 0.0960 – 2.0400
- Beta
- -5.51
- Profit margin
- 0.00%
- Volume
- 1.00k
About Noveris Health Sciences Inc.
Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Noveris Health Sciences Inc. was formerly known as Mydecine Innovations Group Inc. and changed its name to Noveris Health Sciences Inc. in February 2026. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Vancouver, BC, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.